Ziemba B - Search Results

1

Genotoxicity of poly(propylene imine) dendrimers.

Ziemba B, Matuszko G, Appelhans D, Voit B, Bryszewska M, Klajnert B. Ziemba B, et al. Biopolymers. 2012 Aug;97(8):642-8. doi: 10.1002/bip.22056. Biopolymers. 2012. PMID: 22605555

2

In vivo toxicity of poly(propyleneimine) dendrimers.

Ziemba B, Janaszewska A, Ciepluch K, Krotewicz M, Fogel WA, Appelhans D, Voit B, Bryszewska M, Klajnert B. Ziemba B, et al. J Biomed Mater Res A. 2011 Nov;99(2):261-8. doi: 10.1002/jbm.a.33196. Epub 2011 Aug 16. J Biomed Mater Res A. 2011. PMID: 21976451

3

Influence of dendrimers on red blood cells.

Ziemba B, Matuszko G, Bryszewska M, Klajnert B. Ziemba B, et al. Cell Mol Biol Lett. 2012 Mar;17(1):21-35. doi: 10.2478/s11658-011-0033-9. Epub 2011 Nov 16. Cell Mol Biol Lett. 2012. PMID: 22086186 Free PMC article. Review.

4

Modulation of biogenic amines content by poly(propylene imine) dendrimers in rats.

Ciepluch K, Ziemba B, Janaszewska A, Appelhans D, Klajnert B, Bryszewska M, Fogel WA. Ciepluch K, et al. Among authors: ziemba b. J Physiol Biochem. 2012 Sep;68(3):447-54. doi: 10.1007/s13105-012-0158-y. Epub 2012 Feb 28. J Physiol Biochem. 2012. PMID: 22371014

5

Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.

Ziemba B, Halets I, Shcharbin D, Appelhans D, Voit B, Pieszynski I, Bryszewska M, Klajnert B. Ziemba B, et al. J Biomed Mater Res A. 2012 Nov;100(11):2870-80. doi: 10.1002/jbm.a.34222. Epub 2012 May 24. J Biomed Mater Res A. 2012. PMID: 22623362

6

The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.

Franiak-Pietryga I, Ziółkowska E, Ziemba B, Appelhans D, Voit B, Szewczyk M, Góra-Tybor J, Robak T, Klajnert B, Bryszewska M. Franiak-Pietryga I, et al. Among authors: ziemba b. Mol Pharm. 2013 Jun 3;10(6):2490-501. doi: 10.1021/mp400142p. Epub 2013 May 16. Mol Pharm. 2013. PMID: 23641871

7

Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.

Ziemba B, Franiak-Pietryga I, Pion M, Appelhans D, Muñoz-Fernández MÁ, Voit B, Bryszewska M, Klajnert-Maculewicz B. Ziemba B, et al. Int J Pharm. 2014 Jan 30;461(1-2):391-402. doi: 10.1016/j.ijpharm.2013.12.011. Epub 2013 Dec 17. Int J Pharm. 2014. PMID: 24361266

8

How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo.

Shcharbin D, Janaszewska A, Klajnert-Maculewicz B, Ziemba B, Dzmitruk V, Halets I, Loznikova S, Shcharbina N, Milowska K, Ionov M, Shakhbazau A, Bryszewska M. Shcharbin D, et al. Among authors: ziemba b. J Control Release. 2014 May 10;181:40-52. doi: 10.1016/j.jconrel.2014.02.021. Epub 2014 Mar 4. J Control Release. 2014. PMID: 24607663 Review.

9

Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.

Franiak-Pietryga I, Ziółkowska E, Ziemba B, Appelhans D, Maciejewski H, Voit B, Kaczmarek A, Robak T, Klajnert-Maculewicz B, Cebula-Obrzut B, Smolewski P, Borowiec M, Bryszewska M. Franiak-Pietryga I, et al. Among authors: ziemba b. Anticancer Agents Med Chem. 2017;17(1):102-114. Anticancer Agents Med Chem. 2017. PMID: 27349446

10

PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells.

Franiak-Pietryga I, Ostrowska K, Maciejewski H, Appelhans D, Misiewicz M, Ziemba B, Bednarek M, Bryszewska M, Borowiec M. Franiak-Pietryga I, et al. Among authors: ziemba b. Macromol Biosci. 2017 May;17(5). doi: 10.1002/mabi.201600169. Epub 2016 Dec 20. Macromol Biosci. 2017. PMID: 27996200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page